These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19917873)

  • 1. Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity.
    Manrique C; Johnson M; Sowers JR
    Hypertension; 2010 Jan; 55(1):15-7. PubMed ID: 19917873
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
    Cooper-DeHoff RM; Wen S; Beitelshees AL; Zineh I; Gums JG; Turner ST; Gong Y; Hall K; Parekh V; Chapman AB; Boerwinkle E; Johnson JA
    Hypertension; 2010 Jan; 55(1):61-8. PubMed ID: 19917874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
    Moore MJ; Gong Y; Hou W; Hall K; Schmidt SO; Curry RW; Beitelshees AL; Chapman A; Turner ST; Schwartz GL; Bailey K; Boerwinkle E; Gums JG; Cooper-DeHoff RM; Johnson JA
    Pharmacotherapy; 2014 Nov; 34(11):1132-40. PubMed ID: 25202885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I; Hotnes T; Dollerup J; Mogensen CE
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid.
    Gudbrandsson T; Hansson L
    Acta Med Scand Suppl; 1979; 625():86-91. PubMed ID: 34983
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L; van der Does R; Hörrmann M; Machwirth M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R; Widmann L; Uberbacher HJ; Hörrmann M; Machwirth M; Stienen U
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
    Gong Y; McDonough CW; Beitelshees AL; Karnes JH; O'Connell JR; Turner ST; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Johnson JA; Cooper-DeHoff RM
    Pharmacotherapy; 2014 Feb; 34(2):123-30. PubMed ID: 24122840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in fasting glucose after prolonged treatment with a thiazide diuretic.
    Karnes JH; Gong Y; Arwood MJ; Gums JG; Hall KL; Limacher MC; Johnson JA; Cooper-DeHoff RM
    Diabetes Res Clin Pract; 2014 Jun; 104(3):363-9. PubMed ID: 24794890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
    Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
    J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension.
    Messerli FH; Bangalore S; Julius S
    Circulation; 2008 May; 117(20):2706-15; discussion 2715. PubMed ID: 18490538
    [No Abstract]   [Full Text] [Related]  

  • 17. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Lakshman MR; Reda DJ; Materson BJ; Cushman WC; Freis ED
    Arch Intern Med; 1999 Mar; 159(6):551-8. PubMed ID: 10090111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.
    Hirst JA; Farmer AJ; Feakins BG; Aronson JK; Stevens RJ
    Br J Clin Pharmacol; 2015 May; 79(5):733-43. PubMed ID: 25377481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics and beta-blockers: is there a risk for dyslipidemia?
    Weir MR; Moser M
    Am Heart J; 2000 Jan; 139(1 Pt 1):174-83. PubMed ID: 10618579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.